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It is generally believed that separate genes encode for the constant  (C) I and vari- 
able (V) sequences of amino acids that characterize the polypeptide chains of immuno- 
globulins (1). Different C sequences define the particular class of immunoglobulin (Ig) 
chain and the fact that genetic markers for these regions are inherited in Mendelian 
fashion (2-7)  supports the concept of one C gene (8) for each of the 10 or so known 
classes  of Ig chains.  Considerably more than  10 V genes are suspected to encode for 
V  sequences  since  these regions of the Ig chain are responsible for the diversity of 
antibody  specificity  (9-12).  Thus,  a  hypothesis  for  the  translocatlon  of  antibody 
genes  has  become especially  attractive  with  the  discovery that  different  V  region 
subgroups can be associated with the same C region and vice versa  (13-16).  Simply 
stated,  translocation  theories  (9,  17)  require  that  one  of many tandemly linked  V 
genes be transpositioned next to a  C gene before transcription. 
Of some consequence  to  the  above viewpoint  are  the  unexpected  observa- 
tions that we report here for a  congenic partner strain of BALB/c mice. These 
mice were specifically bred so as not to differ from BALB/c mice in any known 
way  except  to  carry  Ig structural  genes  of  the  C57BL/Ka  allotype.  Mouse 
Ig allotypes serve as genetic markers for the closely linked C genes of Ig heavy 
chains  (4, 5).  And so the fact that  the transfer of C57BL/Ka Ig genes to the 
BALB/c genome followed a Mendelian mode of inheritance was in accord with 
expectation.  What was unexpected was that  Ig of BALB/c allotype could be 
elicited  in  one  of our  congenic strains  (ICR  CB-17)  that  was defined  to  be 
homozygous for Ig of the  C57B1/Ka  allotype.  The  conditions  necessary for 
the  expression  of this  "hidden"  alloytype seemed  to be specific.  Further,  the 
BALB/c allotype was detected only on the IgG (IgG2a) class and its appear- 
ance  was  usually  very  transient  and  unpredictable. 
* This work was supported  by U. S. Public Health Service Grants  CA-06927, CA-04946, 
and  RR-05539 from the National  Institutes  of Health,  and by an appropriation  from  the 
Comlnonwealth of Pennsylvania. 
1  Abbreviations used in this paper: BCn, number of introgressive backerosses; C, constant; 
Fn, number of homozygous brother-sister generations; H chain, heavy chain; ICR, Institute 
of Cancer Research; ICR CB-n~ an ICR congenic partner strain  of BALB/c mice (C) where 
C57BL/Ka (B) is  the source of Ig genes and  (n) is the number  of backcross generations; 
L chain, light chain; MOPC, plasmacytomas. 
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What  follows is a  presentation  of the pedigree of our congenic BALB/cICR 
mouse strains, the occasions in which Ig of the "wrong allotype" appeared and a 
preliminary analysis of these mice. 
Materials and Methods 
Nomenclature.--To  facilitate a  clear distinction between Ig classes  and  allotypes we use 
the Potter-Lieberman nomenclature (in parentheses)  (4) to designate the 7S classes of mouse 
IgG1  (IgF), IgG2a (IgG)  and IgG2b  (IgH); and as done elsewhere  (18), we use the small 
case letters a and b to differentiate the Ig ailotypes of BALB/c (Ig a) and C57BL (Ig  b) mouse 
strains.  Thus, for example, the allotype of the IgG class can be denoted as IgG  a or IgG  b. 
Ig structural genes for the V and C segments of heavy (H) and light (L) chains are desig- 
nated  VH,  CH,  VL,  and  C~., respectively. Whenever convenient, Ig structural  genes are 
further specified according to the class of H chain, as for example, Ig CH A, Ig Ca G, etc. 
History of BALB/c Mice Congenic for Ig Genes.--Congenic  mouse strains result from ex- 
perimental attempts  to produce coisogenicity, a  state in which two strains  are genetically 
identical except for a  difference  at a  single locus  (19). Coisogenicity can be approximated 
when one or more genes of one strain  are crossed introgressively onto  the background  of 
another strain (inbred partner strain). Here the intent of breeding is not necessarily the only 
consequence as contaminant genes may also be introduced into the congenic partner strain. 
However, as backcrossing of the specific foreign gene(s) continues, the probability of carrying 
contaminant  genes decreases. 
The use of congenic mice in this study  applies  to BALB/c mice that have different Ig 
structural genes, in which case the congenic partner strains carry Ig structural genes of the 
C57BL/Ka allotype. For these particular strains the foreign chromosomal segment is known 
to include Ig structural genes of the H chain linkage group (4). 
The breeding of such mice was initiated in the laboratory of Dr. M. Potter (National Can- 
cer  Institute,  Bethesda,  Md.)  as  follows  (4):  F1  hybrids  of  C57BL/Ka  X  BALB/c  (o  ~) 
were backcrossed to BALB/c (9); those progeny that showed Ig allotypes of both parental 
strains were again backcrossed to BALB/c ( 9 ). Mating of this kind was continued through 
14 and up to 20 backcross generations, at which times, the allotypicaUy heterozygous mice 
were intercrossed. This yielded offspring  of which approximately one-fourth were phenotyp- 
ically homozygous for Ig of the C57BL/Ka allotype and from which the congenic llne, CB-14 
(BAB-14)  and CB-20 were established by means of brother-sister matings.  2 Our own congenic 
partner strains  of BALB/c mice (ICR CB-17, ICR CB-23, and ICR CB-26)  were derived 
in the same manner from Potter's 13th backcross generation; the only difference  being that 
inbred BALB/c mice of this institute  (BALB/cICR) served as the inbred partner strain for 
all subsequent  backcrosses  and  intercrosses. 3 
Strains  of mice that  are congenic for Ig genes can  be designated  (21) according to  the 
parent strain  (BALB/c), the strain source (C57BL/Ka)  of new Ig genes (Igb),  the number 
(n) of introgressive backcrosses (BC n), and the number of homozygous brother-sister genera- 
tions (Fn), e.g., BALB/cICR.C57BL/Ka Igb/Ig b BC17 F4. In accord with the  abbreviated 
notation of Potter  (personal communication) we will use the symbols ICR CB-n to desig- 
nate: (a) The institution (ICR) in which the congenic line is maintained; (b) the inbred partner 
strain, BALB/c (C); (c) the C57BL/Ka (B) source of Ig genes in the congenic partner strain; 
2 CB-14 is being maintained by Dr. L. Herzenberg (18) and also by Dr. M. Weigert (20); 
both of these investigators designate this congenic line as BAB-14. 
3 We are indebted  to Dr.  Michael Potter,  who initiated  this special breeding program, 
and from whom Dr. Weiler, formerly of this Institute, got the backcross  mice  of  the  13th 
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and (d) the number (n) of backcross generations that preceded the derivation of mice pheno- 
typically  homozygous for Ig  b. 
Mouse Antisera.--Antiallotype sera was made in BALB/clCR and  C57BL/6ICR  mice 
by means of reciprocal immunizations with each other's Ig. Antisera to Ig of the C57BL/6 
or C57BL/Ka allotype (Ig  b)  was  made in BALB/c mice  following repeated injections of 
C57BL/6ICR  hyperimmune  sera  (0.3 ml  serum/injection), whereas  C57BL/6ICR  mice 
made antisera to Ig of the BALB/cICR allotype (Ig  ~) only after many immunizations with 
rabbit red cell ghosts that were first agglutinated with BALB/clCR antibodies and emulsified 
in complete Freund's adjuvant. The monospecificity of both anti-Ig" and anti-Ig  b for allotypic 
determinants unique to IgG was assured after absorption with IgF and IgH immunoglobniins 
derived from the following plasmacytomas (MOPC): IgF  a (MOPC  31), IgH  ~ (MOPC  195), 
IgF  b (MOPC 300), and IgH  b (MOPC  352). 4 Fig. 1 demonstrates this kind of monospecifi- 
city, although indireetiy for IgG  b since as yet there is no IgG  b MOPC tumor available. 
Rabbit Antisera.--New Zealand rabbits were hyperimmunized with Fc fragments of either 
mouse  IgF  (MOPC  31c) or mouse  IgG (MOPC  173). Appropriate combinations of  IgM, 
IgA, IgH, and IgG or IgF from mouse plasmacytomas (MOPC  104E, MOPC  167, MOPC 
195, and MOPC  173  or MOPC 31e) were insolubilized with gluteraldehyde (22) and  used 
to absorb the rabbit antisera. In this way, we obtained class-specific antisera for IgF and IgG. 
Papain Digestion and Immunodectrophoresis.--Salt-precipitated Ig preparations that were 
chromatographically pure were subjected to papain digestion for 60-90  min according to the 
method  of Porter  (23). The resulting  Fab and  Fc fragments were  separated by chroma- 
tography (24) over DEAE-eellulose using a linear salt gradient (0.00.%0.3 M potassium phos- 
phate, pH 8.0). Immunoelectrophoresis  and papaln digestion of mouse  serum was  done  as 
prescribed by  Minna  et  al.  (25). Microimmunoelectrophoresis  (LKB  6800A apparatus, 
LKB Produkter, Stockholm,  Sweden) was carried out in 0.05 M barbital buffer, pH 8.6, at 
7-9  volts/era for  60-90  rain. 
RESULTS 
Pedigree of Congenic BALB/clCR M/ce.--The results of Figs. 2 and 3  show 
the inheritance of mouse IgG  b allotype throughout many backcrosses and inter- 
crosses. Except for two of the twenty crosses, the observed fraction of hereto- 
zygotes (Fig. 2) and homozygotes (Fig. 3) fell within the 95 % confidence inter- 
val that  was  expected of each  sample of  tested progeny,  given a  Mendelian 
mode of inheritance as the null hypothesis. These results,  especially those of 
Fig. 3, confirm the unit-character inheritance of mouse Ig allotypes and served 
as  the  experimental  basis  for  defining  ICR  CB-n  congenic  mice  that  were 
homozygous for Ig  + structural genes. Three such strains are being maintained 
presently:  ICR  CB-17,  ICR  CB-23,  and  ICR  CB-26.  The  ancestors for  the 
ICR CB-17 strain were derived from the first three intercrosses of Fig. 3. 
What is not clear about the results in Fig. 2 is why the observed fractions 
of heterozygotes in the backcrosses approached the expected mean  (0.5)  only 
from  the  lower limit. Neither is it clear what  significance, if any,  should be 
attached to the fluctuation in the yield of heterozygous progeny from BC2~ to 
BC~  (Fig. 2) or to the discrepancy in the yield of homozygotes from two dif- 
ferent intercrosses of BC2~ (Fig. 3). 
4 All mouse  plasmacytomas were  given  to us by Dr.  Michael Potter of  the  National 
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FIG.  1.  The  specificity of antiallotype  sera  to BALB/c immunoglobulin  (Ig  a)  and  to 
C57BL immunoglobulin  (Igb). (a) In the center  well is  C57BL/6  anti-Ig  a with the outer 
wells containing  the following Ig antigens:  IgG  ~ (MOP(;  173) at 0.1 mg/ml (1); BALB/c 
normal  serum  (2); IgG  a  (LPC-1) at 0.1 mg/ml (3); IgF  G (MOPC 31c) at 0.1 mg/ml (4); 
IgG  a Fab fragment  (MOPC 173 Fab) at 0.2 mg/ml (5); and IgH  a (MOPC 195) at 0.1 mg/ml 
(6).  (b) In the center well is BALB/c anti-Ig  b with the following Ig antigens  contained in 
the outer wells: Fc (/) and Fab  (3) preparations,  respectively, of chromatographically  pure 
7S Ig fraction  derived from C57BL/6  mouse serum  (0.3 mg/ml); C57BL/6 normal serum 
(2); BALB/c normal  serum  (4); IgH  b (MOPC  352) at 0.2 mg/ml  (5); and IgF  b (MOPC 
300) at 0.2 mg/ml (6). 
Linkage of Heavy  Chain Genes.--The  antiallotype  sera used  to  define  con- 
genic BALB/cICR mice throughout  all  backcrosses  and  intercrosses  (Figs.  2 
and 3) were monospecific for allotypic determinants unique to IgG. Therefore, 
the detection  of IgF  ~, IgH  b,  and  the inferred presence  of IgA  b in  ICR CB-17 
mice (Table I) demonstrates the close linkage of these Ig structural  genes and 
confirms the work of others  (4,  5). 
Unexpected Observations in  the  ICR  CB-17  Congenic Mouse  Strain.--As  a 
consequence of using  ICR CB-17  mice as recipients  of the  IgM-synthesizing 
plasmacytoma, MOPC 104E, we first observed the appearance of the BALB/c 
allotype  (ICR  CB-17[MOPC-104E]mice).  This  is  shown  in  Fig.  4.  Although 
MOPC  104E  is  a  BALB/c tumor,  this  finding was surprising  because as yet 
no  allotype marker for mouse IgM is known.  Our immediate  inclination  was 516  CONGENIC  MOUSE  STRAINS 
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NUMBER  OF  BACKCROSS  GENERATIONS 
Fzo. 2. Backcross matings of congenic BALB/cICR mouse strains: the percentage of allo- 
typically heterozygous progeny  as  a  function  of  the  number of  introgressive backcrosses 
(BALB/cICR. C57BL/Ka Ig~/Ig  b BCn X  BALB/cICR). The symbols designate the parent 
strain (BALB/clCR) and the strain source (C57BL/Ka) of the new immunoglobulin allotype 
(Ig  b) in mice of the respective BCn. Progeny were tested in the range of 8-15 wk of age; the 
number within each histogram tells how  many mice were  tested.  Given this number and 
the assumption that mouse immunoglobulin allotypes are inherited in Mendelian fashion, the 
95%  confidence interval for  the  expected  fraction  of  heterozygotes at  each  backcross  is 
shown.  The  total Chi-square  between the fraction of heterozygotes observed and that ex- 
pected is X~I =  9.9 (0.5  >  P  >  0.4). 
to accept this as an example of an IgM clone switching to IgG  = analogous to 
the finding with the human myeloma patient, Til (16). At the same time, how- 
ever, other ICR CB-17 mice that were carrying MOPC  195  (IgH  ~) or MOPC 
167  (IgA  a)  showed  the  BALB/c  allotype in  their  serum.  Since  our  antisera 
were  judged  to  be  monospecific for allotypic determinants  unique  to  IgG  a, 
it seemed as if all three conditions were reflecting a property of the host and 
not the plasmacytomas. 
This caused us to check the entire colony of ICR CB-17  breeder mice for 
possible IgG  ~ beginning in March of 1972.  The results are shown in Fig.  5 a. 
The first group  (B)  of mice tested included  all our foundation breeders  (150 
mice) of which 48 mice exhibited IgG  ~ in their serum. In the second group (C) 
of 35 production breeders, only one mouse was positive for IgG  ~. We were sur- 
prised  to find  that  there  was no obvious inheritance  of the  IgG  ~ phenotype 
among the foundation weanlings of Group B as can be seen in Group D. More- 
over, when Group B was retested in May of 1972,  of the original 48 mice that 
had  detectable  IgG  a  in  their  serum,  only  one  remained  positive  for  IgG% 
However, even this mouse  (no.  17  ICR CB-17)  lost its lgG  = phenotype and MELVIN  J.  BOSMA  AND  GAYLE  C.  BOSMA  517 
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INTERCROSSES  OF  BACKCROSS  GENERATIONS  (BC n) 
FIG. 3. Intercross matings of congenic BALB/clCR mouse strains: the percentage of allo- 
typically homozygous progeny as a function of the number of successive intercrosses (BALB/ 
clCR.C57BL/Ka  Ig~/Ig  b  BCn  X  BALB/clCR.C57BL/Ka  Ig~/Ig b BCI~).  The  symbols 
designate the parent strain  (BALB/clCR)  and  the strain source  (C57BL/Ka)  of the new 
Ig  ~ in mice of the respective BCn and Fn.  Progeny were tested in the range of 8-15 wk of 
age; the number within each histogram tells how many mice were tested. Given this num- 
ber and  the assumption that  mouse immunoglobulin allotypes are inherited in Mendelian 
fashion, the 95% confidence interval for the expected fraction of homozygotes at each inter- 
cross is shown. The total Chi-square between the fraction of homozygotes observed and that 
expected is X72  =  4.8  (0.4 >  P  >  0.3). 
TABLE  I 
Allotypes of Different Ig Classes in BALB/c, C57BL and ICR CB-17 Mouse Strains 
Ig class and allotype 
Mouse strain 
BALB/c  C57BL  ICR CB-17 
IgF ~  -4-  --  -- 
IgF  ~  --  -4-  -4- 
IgG a  (G  Ls'7's)  -4-  --  -- 
IgG  b ~G)  -  +  + 
IgH  b (H  Is)  --  -4-  + 
IgA a  (A12,13,14)  -{-  --  _ 
The numbers in parentheses are  the assigned allotypic determinants of Lieberman and 
Potter  (4)  for  the respective Ig classes of BALB/c  (Ig °)  and C57BL  (Ig  b)  mouse  strains. 
Determinant  2G  is still unassigned but is presumably on IgG  b molecules. We  thank  Rose 
Lieberman for typing the IgH and IgA classes, as well as for confirming the presence of IgG  b 
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FIG. 4.  The detection of IgG  a in ICR CB-17 mice bearing MOPC  104E  plasmacytoma 
(ICR CB-17  [MOPC  104E]);  (a)  in outer wells are serum samples  of ICR CB-17  (MOPC 
104E)  mice (well 1)  and of BALB/c normal mice (well 2)  vs. anti-IgG  a in the center well ; 
(b)  in outer wells are serum samples of ICR CB-17  (MOPC  104E)  mice (well 2)  and ICR 
CB-17 mice bearing IgG  a plasmacytomas (LPC-1 in well 1 and MOPC 173 in well 3). 
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CHRONOLOGICAL TIME (MONTH/YEAR) 
FIG. 5.  (a)  The appearance  of IgG  a in the ICR CB-17 mouse colony; the percentage of 
mice positive for IgG  a as a function of chronological time. The age range and the number of 
mice positive for IgG  ° per number tested is as follows: Group A, 8-12-wk old production stock, 
0/115; Group II, 1-13-mo old foundation breeders, 48/150; Group C, 12-25-wk old production 
breeders,  1/35;  Group  D,  5-9-wk  old foundation  weanlings,  3/211;  Group  E,  retesting  of 
Group B,  1/150; and  Group F, 9-20-wk  old production stock, 0/236.  (b)  Random sampling 
of ICR mouse colony for the presence of Sendai virus; the percentage of mice serologically 
positive for Sendal virus as a  function of chronological time. The number of mice tested at 
each interval is as follows: Group A, 30; Group B, 30; Group C, 27; Group D, 20; Group E, 
25; Group F, 24; and Group G, 100. MELVIN  J.  BOSMA  AND  GAYLE  C.  BOSMA  519 
died shortly thereafter (see Fig.  6).  To round  out  this  exhaustive screen of 
ICR CB-17 mice, it was fortuitous that earlier we had checked some 200 ICR 
CB-17 production mice for IgG  a and IgG  b in October of 1972 (Group A); sub- 
sequent testing of ICR  CB-17 production stock has consistently failed to re- 
veal IgG  ~ (Group E). 
The transient appearance of the IgG  ~ phenotype in the ICR CB-17 mouse 
colony suggested to us that the expression of IgG  ° might have been a  conse- 
quence of some infectious agent. Further support for this idea came from the 
results of serological tests for Sendal virus in mice representative of all ICR 
Fla. 6. The transient appearance of IgG  a in mouse 17 ICR CB-17  of Fig. 5 a, Group E 
Serum samples that were obtained at different intervals of time (5/23, 5/25, 5/30, 6/7, and 
6/13)  are in the outer wells numbered  1-5,  respectively. Anti-IgG  a  is in  the center well. 
strains  (Fig.  5 b).  These and  other tests are performed routinely to monitor 
the general health in the ICR animal  colony. What is clear from Fig.  5 b is 
that  the entire ICR mouse colony experienced a  Sendai epizootic in  the fall 
of 1971 which reached its peak in February of 1972. As can be seen in Fig. 5, 
the time-course of the Sendai infection preceded that of the IgG  a detection in 
ICR CB-17 mice. This was consistent with the idea that some infectious agent 
(not  necessarily Sendai  virus)  could  be partly  responsible  for the  transient 
expression of IgG  a in ICR CB-17 mice. Possibly the putative agent was acting 
as  an  antigen  to  stimulate  an  unusual  IgG  a immune  response. 
The  Appearance  of  an  IgG~-Synthesizing  Plasmacytoma  in  an  ICR  CB-17 
Mouse.--To  further test the idea  that  an infectious agent was in  some way 
responsible  for IgG  ~ in  ICR  CB-17  mice,  preparations  of bacterial  cultures 
that were obtained from the blood samples of sick-looking ICR  CB-17 mice 520  CONGENIC  MOUSE  STRAINS 
(organisms  that  were  later  identified  in  these  cultures  included  Pasturella 
pneumotropic  and  Streptococcus faecalis  plus  Sendal  and  Reo  virus)  were  in- 
jected into six healthy ICR CB-17 recipients. About 1 mo after three such i.p. 
injections  (0.3  ml/injection/mouse),  some  of  the  recipients  suddenly  died. 
The  three  surviving  ICR  CB-17  mice  (numbered  2,  3,  4)  were  bled;  no.  3 
ICR CB-17  and no. 4  ICR CB-17 showed IgG  a in their serum and  1 wk later 
so did mouse no.  2  ICR  CB-17  (mouse 4  ICR  CB-17  died 1  day after being 
bled). The  results for no.  3  ICR  CB-17  and  no.  2  ICR  CB-17  are  shown  in 
Fig.  7. The lymph node pathology of mouse 3  ICR CB-17  indicated it had  a 
Fla. 7. The detection of IgG  a in sick ICR CB-17 mice. (a) The outer wells contain serum 
samples of mouse 2 ICR CB-17 (well 1) and mouse 3 ICR CB-17 (2) vs.  anti-IgG  ~ in the 
center well;  (b) The outer wells contain serum  samples of mouse 3 ICR CB-17 (1) and an 
ICR CB-17 mouse bearing MOPC-173  (2) vs. anti-IgG  ~ in the center. 
plasma cell leukemia which we were able to  transplant successfully into other 
ICR CB-17 mice. This tumor (ICR PC 3) has now been passaged for 11 genera- 
tions, during which  time its pathology has progressed to  that  of a  plasmacy- 
toma. 5 The ICR PC 3  plasmacytoma continues to synthesize large quantities 
of IgG  ~. Although the lymphoid tissue of mouse  2  ICR CB-17  was judged to 
be  that  of  an  incipient leukemia,  the  transfer  of  this  tissue  to  X-irradiated 
ICR CB-17 mice did not result in a  tumor or an IgG  ~ response in these recipi- 
ents. 
We have since observed IgG" in other ICR CB-17 mice that were either made 
5 The tissue pathology of these mice was diagnosed by Dr. Philip Custer of this Institute. MELVIN  ]'.  BOSMA  AND  GAYLE  C.  BOSMA  521 
sick  with  X-irradiation  or  were  generally  debilitated  with  a  transplanted 
plasmacytoma (MOPC  104E). Whether utilizing the lymphoid tissue of these 
mice for cell transfer to other ICR CB-17 recipients or using identical proce- 
dures to those mentioned above, we have not been able to reliably elicit IgG  a in 
ICR CB-17 mice. When we succeeded in doing so, the IgG  a phenotype usually 
disappeared  in  a  few weeks  or  the  mice died.  Also,  the  IgG  a phenotype  in 
ICR  CB-17  serum was not removed by absorption with the previously used 
bacterial  preparations.  Other  attempts  to  induce  IgG  a  production  in  ICR 
CB-17  mice by injection with  live Sendai  virus,  or repeated  injections  with 
different  immunogens  (dextran,  R-36A  pneumococcal  vaccine,  strep-DNP, 
lipopolysaccharides,  various  red  cell  antigens,  and  protein  antigens)  have 
failed2 
Analysis  of ICR CB-17 Mice Showing IgG~.--Using the  serum  of several 
ICR CB-17 mice that had detectable IgG  ~, we determined what strain source 
of IgF was present  (Fig.  8).  Following papain digestion and immunoelectro- 
phoresis of these  serum  samples, we used  rabbit antiserum monospecific for 
mouse  IgF  to  differentiate  the  IgF of BALB/c  (IgF  ~)  from that  of C57BL 
(IgFb). This is possible because the Fc fragment of IgF  ~ migrates farther to 
the anode than the Fc fragment of IgF  b (4,  25). Accordingly, in Fig.  7 it can 
be seen with two examples (sera of mouse 2  ICR CB-17  and of ICR CB-17 
[MOPC  104E]  mice)  that only IgF  b was found as opposed to the presence of 
both  IgF  a and  IgF  b in  the  serum o[ F1  BALB/cICR X  ICR  CB-17  hybrid 
mice. We presume that  the lack of detectable IgF  b in the serum of mouse 3 
ICR CB-17 was because the large quantity of tumor protein (IgG  ~) caused a 
depression in the normal synthesis of IgF  b. 
As with IgF, the Fc fragments of BALB/c IgG migrate farther to the anode 
than those of C57BL. Therefore, with the same techniques as above, we used 
rabbit antiserum directed against mouse IgG to assure ourselves that our anti- 
allotype sera was not precipitating the IgG  ~ in ICR CB-17 mice on the basis 
of some unusual  determinants  (idiotypes)  that might be associated with  the 
combining site specificity of these IgG  ° molecules. 
A  summary of what  allotypes were found  among Ig classes of the  heavy 
chain linkage group is shown in Table II for ICR CB-17 normal sera, sera of 
mouse  2  ICR  CB-17  and  of ICR  CB-17  (MOPC  104E)  mice.  It should  be 
emphasized  here  that  whenever  IgG  ~ was  detected  in  ICR  CB-17  mice,  it 
was always in addition to the normal presence of IgG  b. Also, it was not possible 
to determine if IgH  ~ was present in these ICR CB-17 experimental mice, be- 
cause antisera monospecific for allotypic determinants unique to IgH  a was not 
available. 
s The injection of ICR CB-17 mice with Sendal virus was carried out at Oak Ridge National 
Laboratory, Oak Ridge, Tenn., by Dr. Conrad Richter. ICR CB-17 mice were immunized to 
dextran by Dr. Martin Weigert of the Salk Institute,  San Diego, Calif. R-36A pneumoccal 
vaccine was given to us by Dr. Alex Tomasz of The Rockefeller University, New York. 522  CONGENIC  MOUSE  STRAINS 
Fro.  8.  Immunoelectrophoretic migratigns of Fc fragments of IgF  derived from papain- 
digested BALB/cICR  and  ICR  CB-17  normal  mouse  sera and  from papain-digested ICR 
CB-17  experimental  mouse  sera.  All  troughs  contained  rabbit  antiserum  that  was  mono- 
specific for mouse IgF, i.e., for determinants on the Fc portion. The wells were loaded with 
the following digested sera: BALB/cICR (wells 1, 4, and 7); ICR CB-17 (3 and 6);  FI hybrid 
BALB/cICR  X  ICR  CB-17  (2); ICR CB-17  (MOPC  104E)  (5);  mouse 2  ICR CB-17  (8); 
and mouse 3 ICR CB-17  (9). 
TABLE  II 
Allotypes  of Different  Ig Classes in No. 2 ICR CB-17 and ICR CB-17(MOPC 104E)  Experi- 
mental  Mice and in ICR CB-17 Normal Mice 
Ig class and allotype 
ICR CB-17 mice 
ICR CB-17  ICR CB-17  No. 2 ICR CB-17  (MOPC  104E) 
IgF  ~  -  -  - 
IgF  b  +  +  + 
igG a  (G  t ,63,~)  +  +  _ 
IgG  b (2G)  +  +  + 
IgH  b (H  16)  -I-  -[-  -I- 
IgA a  (A12,13,14)  __  --  __ 
The  numbers in parentheses are  the  assigned allotypic determinants of Lieberman  and 
Potter  (4)  for  the respective Ig classes of BALB/c  (Ig ~)  and  C57BL  (Ig  b)  mouse  strains. 
Determinant  2G  is  still unassigned but is presumably on IgG  b molecules. We  thank  Rose 
Lieberman for  typing  the IgH  and  IgA classes, as well as  for  confirming the presence  of 
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DISCUSSION 
The preceding results showed that the transient appearance of IgG  a in ICR 
CB-17  mice was correlated with general sickness or overall debilitation result- 
ing from the growth of transplanted plasmacytomas. This suggested to us that 
an infectious agent normally latent in BALB/c mice might have caused ICR 
CB-17 mice to produce IgG  a. 
In our attempts to account for hidden IgG  a structural genes in ICR CB-17 
mice, we will consider the following possible sources: (a) that BALB/c recom- 
binant genes reside in some ICR CB-17  mice, the detection of which requires 
specific  antigenic  stimulation  and  possibly  the  action  of  specific  regulator 
genes; (b) that IgG~-like genes are carried on the C57BL/Ka chromosome in a 
repressed  state  (these  same  genes  might  be  derepressed  under  appropriate 
conditions when introduced to  the  BALB/c genome);  and  (c)  that viruses 
normally latent and indigenous to BALB/c mice carry some IgG  ~ information. 
We would presume that some forms of stress place ICR CB-17  cells at great 
risk to viral transformation, an event that results in transient IgG  ~ synthesis 
and possible 13anphoid neoplasia. 
The first consideration accounts for the origin of IgG" by postulating that 
some ICR CB-17 mice carry a recombinant Ig CaG" gene(s) that was derived 
from the BALB/c mouse strain during the introgressive backcrossing of ICR 
CB-17  ancestors. As the first of two explanations for the normal silence of this 
recombinant gene, we postulate the following: (a)  that  the recombinational 
event included one Ig Ca G" gene and a few associated Va genes; and (b) that 
specific  amplification of  CH gene expression  (clonal  cell proliferation)  is de- 
pendent on Va gene stimulation. The latter postulate is consistent with evi- 
dence for the close linkage of V and C genes (26, 27); with the selective stimu- 
lation of antibody allotypes by different haptens in  F1 hybrid C57BL/6  X 
C3H/HeN mice (28);  and with that reported by Tosi et al. (29), namely, that 
the quantitative expression of allotype markers in the Cn region of rabbit Ig 
molecules is influenced by those in the V.  regions. Further evidence can be 
cited in support of the regulation of C gene expression by V gene stimulation. 
For example, the ratio of X/x-chains varies greatly in different animal species 
(13, 30, 31)  as does the ratio of different rabbit K-chains (those with five half- 
cystine residues vs. those containing seven half-cystine residues) with different 
K-chain allotypes (32). 
In keeping with the tandem arrangement of Va and Ca genes proposed by 
others (9, 17), in which a single cluster of many Va genes is followed by single 
copies  of  different  Ca  genes,  most  reciprocal  recombinations  involving  C• 
genes would include associated Va genes3 However infrequent such recombi- 
nations, we expect  that random translocations of the involved V~  genes to 
adjacent Ca genes would lead to the serological  detection of recombinant Ca 
This is not to exclude the possibility that repeating clusters of Va and Ca genes follow 
in series or  that clusters of repeating VE genes alternate  with different Cn genes (existing 
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genes. Therefore, in scoring for ICR CB-17 homozygotes (see Fig. 3), one would 
select against most recombinant mice as these would be indistinguishable from 
the heterozygotes. If, on the other hand, a  gene recombination included only 
one CH gene and very few associated VH genes, it might not be detected for lack 
of antigenic stimulation.  In  other words,  any antibody precursor cell of an 
ICR  CB-17  recombinant mouse that  synthesizes IgG  a would  go undetected 
unless the appropriate antigen were normally present to induce enough clonal 
proliferation of these cells to make IgG  a detectable in the serum. The specific 
candidate that caused proliferation of cells expressing IgG  a recombinant genes 
would presumably be some infectious agent that  acted as an  antigen. Thus, 
our inability to reliably cause ICR CB-17 mice to synthesize IgG  a would result 
from the ill-defined conditions of stress that activate the putative agent and 
also from not knowing which ICR CB-17 mice were the recombinant mice. 
Relevant to our observations are those of Blomberg et al. (20) that pertain 
to a  relative of the ICR CB-17 congenic line. These investigators found that 
the  BAB-14  congenic  line  (see  footnote  2)  gave  an  unexpected  antibody 
response to dextran; i.e.,  BAB-14 mice responded as well  to dextran  as did 
BALB/c mice, instead of responding poorly as do C57BL/6 mice. A poor anti- 
body response was expected since the use of recombinant inbred strains indi- 
cated  that responsiveness to dextran was linked to C~ genes. Therefore, the 
BAB-14 antibody response was  best  explained by postulating  a  recombina- 
tional event between the CH gene locus of C57BL and the BALB/c locus con- 
taining V~ genes for dextran. 
What is inconsistent with the first explanation for the silence of a  recom- 
binant  Ig  CH  G ~ gene was  our inability to remove the  IgG  a in  ICR  CB-17 
serum after absorption with the previously used bacterial preparations. And 
so perhaps the lack of IgG  a detection in normal ICR CB-17 mice relates to a 
more basic deficiency than that of not having the appropriate antigen. There- 
fore,  a  second  explanation  to  account  for the  quiescence of a  recombinant 
Ig C~  G ~ gene is as follows: (a)  that the differentiation of stem cells into Ig- 
bearing precursor cells requires the derepression oF specific regulator genes to 
initiate the joining of any one VH gene with a CH gene; (b) that the specificity 
of a  given "joining enzyme" is restricted to one of two allelic sets of VH and 
CH genes; and  (c) that during the backcrossing of ICR CB-17 ancestors, one 
selected against the acquisition of BALB/c regulator genes on the ICR CB-17 
chromosome  but  not  necessarily  against  the  accumulation  of  recombinant 
V~ and CH genes. According to this line of reasoning, the Ig Ca G" recombinant 
gene in ICR CB-17 mice would not be transcribed for lack of a BALB/c regu- 
lator gene(s).  How  this  regulator gene  deficiency might  have  been  circum- 
vented or altered in ICR CB-17 mice that exhibited IgG  ~ remains unclear. 
The above explanation could also be applied to a second consideration for the 
genetic origin of IgG  ~ in ICR CB-17 mice, namely, that the structural genes 
for the IgG  ~ molecule reside in C57BL/Ka mice in a  repressed state.  In this MELVIN  J.  BOSMA AND  GAYLE C.  BOSMA  525 
context, it becomes especially important to know whether the  unassigned ~G 
allotypic determinant in C57BL mice (33)  is indeed a true genetic marker for 
IgG. 
As a last possible consideration, we feel it must be conceded that the infor- 
mation for the IgG  ~ molecule in ICR CB-17 mice could be carried as an episome 
(virus). Normally latent and indigenous to BALB/c mice, such a virus would 
not have been selected against  in the ICR CB-17 pedigree. However, under 
some forms of stress to the lymphoid system, the virus may become infectious 
and possibly cause incipient neoplasia accompanied by IgG" production. The 
final outcome may lead to a  tumor. This explanation succeeds fairly well in 
accounting for our observations,  especially the  no.  3  ICR  CB-17  leukemia 
mouse.  Clearly, more experiments with ICR CB-17 mice are required before 
it can be decided which of the three considerations, if any, is likely to be cor- 
rect. 
SUMMARY 
This paper derives from the unexpected observations of the "wrong immuno- 
globulin  allotype" in  a  congenic partner  strain  of  BALB/c  mice  from  the 
Institute  of Cancer Research  (ICR  CB-17).  These mice were specially bred 
so  as  not  to  differ from BALB/c mice in  any known  way  except to  carry 
immunoglobulin structural genes of the C57BL/Ka allotype. In this respect, 
ICR CB-17 mice were defined as allotypically homozygous according to the 
Mendelian inheritance of mouse allotype markers. The homozygosity of these 
mice was challenged, however, when in certain instances immunoglobulins of 
the BALB/c allotype appeared in the serum of some ICR CB-17 mice. The 
appearance of this hidden allotype was usually transient and only associated 
with immunoglobulins of  the  IgG  (IgG2a)  class.  The  implications  of  these 
findings for the inheritance and expression of immunoglobulin structural genes 
are discussed. 
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well as his criticisms and those of Dr. Martin Weigert during the preparation of this manu- 
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